|
|
Prepublished online as a Blood First Edition Paper on December 12, 2002; DOI 10.1182/blood-2002-04-1204.
Previous Article | Table of Contents | Next Article 
Blood, 15 April 2003, Vol. 101, No. 8, pp. 2940-2954
REVIEW ARTICLE
Signal transducer and activator of transcription proteins in
leukemias
Mustafa Benekli,
Maria R. Baer,
Heinz Baumann, and
Meir Wetzler
From the Leukemia Section, Department of Medicine, and
Department of Molecular and Cellular Biology, Roswell Park Cancer
Institute, Buffalo, NY.
Signal transducer and activator of transcription (STAT)
proteins are a 7-member family of cytoplasmic transcription factors that contribute to signal transduction by cytokines, hormones, and
growth factors. STAT proteins control fundamental cellular processes,
including survival, proliferation, and differentiation. Given the
critical roles of STAT proteins, it was hypothesized that inappropriate
or aberrant activation of STATs might contribute to cellular
transformation and, in particular, leukemogenesis. Constitutive
activation of mutated STAT3 has in fact been demonstrated to result in
transformation. STAT activation has been extensively studied in
leukemias, and mechanisms of STAT activation and the potential role of
STAT signaling in leukemogenesis are the focus of this review. A better
understanding of mechanisms of dysregulation of STAT signaling pathways
may serve as a basis for designing novel therapeutic strategies that
target these pathways in leukemia cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Vempati, C. Reindl, U. Wolf, R. Kern, K. Petropoulos, V. M. Naidu, C. Buske, W. Hiddemann, T. M. Kohl, and K. Spiekermann
Transformation by Oncogenic Mutants and Ligand-Dependent Activation of FLT3 Wild-type Requires the Tyrosine Residues 589 and 591
Clin. Cancer Res.,
July 15, 2008;
14(14):
4437 - 4445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Xiang, Y. Zhao, V. Mitaksov, D. H. Fremont, Y. Kasai, A. Molitoris, R. E. Ries, T. L. Miner, M. D. McLellan, J. F. DiPersio, et al.
Identification of somatic JAK1 mutations in patients with acute myeloid leukemia
Blood,
May 1, 2008;
111(9):
4809 - 4812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ferrajoli, S. Faderl, Q. Van, P. Koch, D. Harris, Z. Liu, I. Hazan-Halevy, Y. Wang, H. M. Kantarjian, W. Priebe, et al.
WP1066 Disrupts Janus Kinase-2 and Induces Caspase-Dependent Apoptosis in Acute Myelogenous Leukemia Cells
Cancer Res.,
December 1, 2007;
67(23):
11291 - 11299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. I. Brown, J. Hulitt, J. Fish, C. Sheen, M. Bruno, Q. Xu, M. Carroll, J. Fang, D. Teachey, and S. A. Grupp
Thymic Stromal-Derived Lymphopoietin Induces Proliferation of Pre-B Leukemia and Antagonizes mTOR Inhibitors, Suggesting a Role for Interleukin-7R{alpha} Signaling
Cancer Res.,
October 15, 2007;
67(20):
9963 - 9970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Masri, W. Xu, S. A. A. Comhair, K. Asosingh, M. Koo, A. Vasanji, J. Drazba, B. Anand-Apte, and S. C. Erzurum
Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension
Am J Physiol Lung Cell Mol Physiol,
September 1, 2007;
293(3):
L548 - L554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Vempati, C. Reindl, S. K. Kaza, R. Kern, T. Malamoussi, M. Dugas, G. Mellert, S. Schnittger, W. Hiddemann, and K. Spiekermann
Arginine 595 is duplicated in patients with acute leukemias carrying internal tandem duplications of FLT3 and modulates its transforming potential
Blood,
July 15, 2007;
110(2):
686 - 694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Kataoka, T. Ioka, Y. Tsukamoto, M. Matsumura, S. Ishiguro, and Y. Nishizawa
Nuclear Expression of STAT5 in Intraductal Papillary Mucinous Neoplasms of the Pancreas
International Journal of Surgical Pathology,
July 1, 2007;
15(3):
277 - 281.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Choudhary, C. Brandts, J. Schwable, L. Tickenbrock, B. Sargin, A. Ueker, F.-D. Bohmer, W. E. Berdel, C. Muller-Tidow, and H. Serve
Activation mechanisms of STAT5 by oncogenic Flt3-ITD
Blood,
July 1, 2007;
110(1):
370 - 374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Cain, Z. Xiang, J. O'Neal, F. Kreisel, A. Colson, H. Luo, L. Hennighausen, and M. H. Tomasson
Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage
Blood,
May 1, 2007;
109(9):
3906 - 3914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Irish, N. Anensen, R. Hovland, J. Skavland, A.-L. Borresen-Dale, O. Bruserud, G. P. Nolan, and B. T. Gjertsen
Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53
Blood,
March 15, 2007;
109(6):
2589 - 2596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Harir, C. Pecquet, M. Kerenyi, K. Sonneck, B. Kovacic, R. Nyga, M. Brevet, I. Dhennin, V. Gouilleux-Gruart, H. Beug, et al.
Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias
Blood,
February 15, 2007;
109(4):
1678 - 1686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wetzler, M. T. Brady, E. Tracy, Z.-R. Li, K. A. Donohue, K. L. O'Loughlin, Y. Cheng, A. Mortazavi, A. A. McDonald, P. Kunapuli, et al.
Arsenic Trioxide Affects Signal Transducer and Activator of Transcription Proteins through Alteration of Protein Tyrosine Kinase Phosphorylation.
Clin. Cancer Res.,
November 15, 2006;
12(22):
6817 - 6825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Hu and J. Nicholas
Signal Transduction by Human Herpesvirus 8 Viral Interleukin-6 (vIL-6) Is Modulated by the Nonsignaling gp80 Subunit of the IL-6 Receptor Complex and Is Distinct from Signaling Induced by Human IL-6
J. Virol.,
November 1, 2006;
80(21):
10874 - 10878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Mercher, G. Wernig, S. A. Moore, R. L. Levine, T.-L. Gu, S. Frohling, D. Cullen, R. D. Polakiewicz, O. A. Bernard, T. J. Boggon, et al.
JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model
Blood,
October 15, 2006;
108(8):
2770 - 2779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Reiterer and A. Yen
Inhibition of the janus kinase family increases extracellular signal-regulated kinase 1/2 phosphorylation and causes endoreduplication.
Cancer Res.,
September 15, 2006;
66(18):
9083 - 9089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Brown, C. R. Wilkinson, S. R. Waterman, C. H. Kok, D. G. Salerno, S. M. Diakiw, B. Reynolds, H. S. Scott, A. Tsykin, G. F. Glonek, et al.
Genetic regulators of myelopoiesis and leukemic signaling identified by gene profiling and linear modeling
J. Leukoc. Biol.,
August 1, 2006;
80(2):
433 - 447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Khanna-Gupta, H. Sun, T. Zibello, L. Lozovatsky, P. K. Ghosh, D. C. Link, M. L. McLemore, and N. Berliner
p120 nucleolar-proliferating antigen is a direct target of G-CSF signaling during myeloid differentiation
J. Leukoc. Biol.,
May 1, 2006;
79(5):
1011 - 1021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Lucet, E. Fantino, M. Styles, R. Bamert, O. Patel, S. E. Broughton, M. Walter, C. J. Burns, H. Treutlein, A. F. Wilks, et al.
The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor
Blood,
January 1, 2006;
107(1):
176 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Lin, R. Lai, L. R. Chirieac, C. Li, V. A. Thomazy, I. Grammatikakis, G. Z. Rassidakis, W. Zhang, Y. Fujio, K. Kunisada, et al.
Constitutive Activation of JAK3/STAT3 in Colon Carcinoma Tumors and Cell Lines: Inhibition of JAK3/STAT3 Signaling Induces Apoptosis and Cell Cycle Arrest of Colon Carcinoma Cells
Am. J. Pathol.,
October 1, 2005;
167(4):
969 - 980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Blancafort, E. I. Chen, B. Gonzalez, S. Bergquist, A. Zijlstra, D. Guthy, A. Brachat, R. H. Brakenhoff, J. P. Quigley, D. Erdmann, et al.
Genetic reprogramming of tumor cells by zinc finger transcription factors
PNAS,
August 16, 2005;
102(33):
11716 - 11721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. B. Guo, J. Lu, T. Li, Z. Lu, G. Xu, M. Xu, L. Lu, and W. Dai
Insulin-activated, K+-channel-sensitive Akt pathway is primary mediator of ML-1 cell proliferation
Am J Physiol Cell Physiol,
August 1, 2005;
289(2):
C257 - C263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Choudhary, J. Schwable, C. Brandts, L. Tickenbrock, B. Sargin, T. Kindler, T. Fischer, W. E. Berdel, C. Muller-Tidow, and H. Serve
AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations
Blood,
July 1, 2005;
106(1):
265 - 273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Liu, K. M. McBride, and N. C. Reich
STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-{alpha}3
PNAS,
June 7, 2005;
102(23):
8150 - 8155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Heck, D. Lengenfelder, M. Schmidt, I. Muller-Fleckenstein, B. Fleckenstein, B. Biesinger, and A. Ensser
T-Cell Growth Transformation by Herpesvirus Saimiri Is Independent of STAT3 Activation
J. Virol.,
May 1, 2005;
79(9):
5713 - 5720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Jenkins, A. W. Roberts, M. Najdovska, D. Grail, and M. Ernst
The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis
Blood,
May 1, 2005;
105(9):
3512 - 3520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Uddin, A. R. Hussain, K. A. Al-Hussein, P. S. Manogaran, A. Wickrema, M. I. Gutierrez, and K. G. Bhatia
Inhibition of Phosphatidylinositol 3'-Kinase/AKT Signaling Promotes Apoptosis of Primary Effusion Lymphoma Cells
Clin. Cancer Res.,
April 15, 2005;
11(8):
3102 - 3108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Wang, P. Cherukuri, and J. Luo
Activation of Stat3 Sequence-specific DNA Binding and Transcription by p300/CREB-binding Protein-mediated Acetylation
J. Biol. Chem.,
March 25, 2005;
280(12):
11528 - 11534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Maeda, F. Yagasaki, M. Ishikawa, N. Takahashi, and M. Bessho
Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML
Blood,
March 1, 2005;
105(5):
2115 - 2123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tonozuka, Y. Minoshima, Y. C. Bao, Y. Moon, Y. Tsubono, T. Hatori, H. Nakajima, T. Nosaka, T. Kawashima, and T. Kitamura
A GTPase-activating protein binds STAT3 and is required for IL-6-induced STAT3 activation and for differentiation of a leukemic cell line
Blood,
December 1, 2004;
104(12):
3550 - 3557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-C. Albrecht, B. Biesinger, I. Muller-Fleckenstein, D. Lengenfelder, M. Schmidt, B. Fleckenstein, and A. Ensser
Herpesvirus Ateles Tio Can Replace Herpesvirus Saimiri StpC and Tip Oncoproteins in Growth Transformation of Monkey and Human T Cells
J. Virol.,
September 15, 2004;
78(18):
9814 - 9819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Siavash, N.G. Nikitakis, and J.J. Sauk
SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION: INSIGHTS INTO THE MOLECULAR BASIS OF ORAL CANCER
Critical Reviews in Oral Biology & Medicine,
September 1, 2004;
15(5):
298 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kato, E. Sakamoto, H. Kutsuna, A. Kimura-Eto, F. Hato, and S. Kitagawa
Proteolytic Conversion of STAT3{alpha} to STAT3{gamma} in Human Neutrophils: ROLE OF GRANULE-DERIVED SERINE PROTEASES
J. Biol. Chem.,
July 23, 2004;
279(30):
31076 - 31080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Kurzer, L. S. Argetsinger, Y.-J. Zhou, J.-L. K. Kouadio, J. J. O'Shea, and C. Carter-Su
Tyrosine 813 Is a Site of JAK2 Autophosphorylation Critical for Activation of JAK2 by SH2-B{beta}
Mol. Cell. Biol.,
May 15, 2004;
24(10):
4557 - 4570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ikezoe, T. Saito, K. Bandobashi, Y. Yang, H. P. Koeffler, and H. Taguchi
HIV-1 protease inhibitor induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2
Mol. Cancer Ther.,
April 1, 2004;
3(4):
473 - 479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Heath and N. C. P. Cross
Critical Role of STAT5 Activation in Transformation Mediated by ZNF198-FGFR1
J. Biol. Chem.,
February 20, 2004;
279(8):
6666 - 6673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-W. Ni, H.-J. Hsieh, Y.-J. Chao, and D. L. Wang
Shear Flow Attenuates Serum-induced STAT3 Activation in Endothelial Cells
J. Biol. Chem.,
May 23, 2003;
278(22):
19702 - 19708.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|